Discovery Life Sciences Launches World-Class Proteomic Services Division Supported By Leading Technology Partners
Creates a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis to support drug and diagnostic development
December 14, 2022
Read MoreDiscovery Life Sciences Acquires AllCells
July 12, 2022
Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells® , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than ...
Read More
Discovery Life Sciences’ HudsonAlpha Discovery Becomes One of the World’s Largest PacBio HiFi Sequencing Service Providers
ESTABLISHES A SINGULAR, LARGE-SCALE HIFI LONG READ SEQUENCING SERVICE FOR THE BIOPHARMACEUTICAL INDUSTRY
June 7, 2022
Read MoreDiscovery Life Sciences To Acquire Gentest Business From Corning Incorporated
May 2, 2022
Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering
Read More
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
January 10, 2022
Delivery of 100,000 Samples of Capacity Annually to the Market, Empowering Genomics Researchers to Add Deep, Unbiased Proteomics Analysis to their Studies
Read More
Discovery Life Sciences Acquires In Vitro ADMET Laboratories
December 2, 2021
Biospecimen Leader Gains World’s Largest Hepatocyte Inventory And World-Renowned Scientific Leader With Latest Acquisition
Read More
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
